Dr. Vincent Marion has a PhD in physiology from Maastricht University, The Netherlands. He also has a Master’s degree in Structural and functional biochemistry with a specialisation in protein biological function from the University of Paul Sabatier, France. With more than 10 years’ experience in studying rare genetic diseases and the biology of the adipocyte, he is an expert in the endocrine connections of the adipose tissue. He is managing a research group studying targeted rare genetic disorders to design tailored innovative therapies at the Laboratory of Medical Genetics of Strasbourg, France, where he also serves as the Deputy Director since 2016. He is author to 50 publications and has filed 10 patents relating to innovative therapeutic approaches. In July 2022 he founded AdipoPharma, formerly ALMS Therapeutics.